Top Markets
#1 Akedo Akedo +73.71%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.71%
#4 Cross Cross +43.52%
#5 Black Phoenix Black Phoenix +33.78%
#6 Cap Cap +25.61%
#7 Velvet Velvet +25.32%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.62%
#9 DoubleZero DoubleZero +12.53%
#10 Humanity Humanity +10.30%
Coin of the day
Akedo Akedo
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Niki BioSolutions, Inc. Niki BioSolutions, Inc.

Niki BioSolutions, Inc.

NIKI
Pozycja w akcjach #39001
Niki BioSolutions is a biopharmaceutical company that resulted from the merger... Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
Cena akcji
$8.54
Ostatnia synchronizacja: 2026-08-13
Kapitalizacja rynkowa
$695.47K
Zmiana (1 dzień)
-10.86%
Zmiana (1 rok)
-94.15%
Kraj
US
Handel Niki BioSolutions, Inc. (NIKI)

Kategoria

Healthcare
Historia stopy dywidendy dla Niki BioSolutions, Inc. (NIKI)
Stopa dywidendy (TTM) dla Niki BioSolutions, Inc. (symbol akcji: NIKI) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Niki BioSolutions, Inc. (NIKI) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.65%
BE